Orion bottoms Helsinki blue chip index on Q4 profit miss

Orion Oyj

12/02/2026 11:20

** Shares in Finnish pharma company Orion ORNBV.HE fall around 10% after it missed Q4 profit estimates

** Jefferies says EBIT missed mainly due to higher‑than‑expected research and development (R&D) costs and a weaker sales mix, especially in branded products

** Orion's Q4 quarterly operating profit is at EUR 328.1 million ($389.78 million), below the Vara Research consensus of EUR 346.7 million

** The stock sits at the bottom of the Helsinki blue chip .OMXH25

($1 = 0.8418 euros)

 (Reporting by Elviira Luoma)

 ((Elviira.luoma@thomsonreuters.com))